Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Martin, M; Garcia-Saenz, JA; Manso, L; Llombart, A; Cassinello, A; Atienza, M; Ringeisen, F; Ciruelos, E.

Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancer

Future Oncology. 2020; 16(33): 2763-2778 Nº de citas: 15 [doi:10.2217/fon-2020-0604]

Metro, G; Banna, GL; Signorelli, D; Gili, A; Galetta, D; Galli, G; Economopoulou, P; Roila, F; Friedlaender, A; Camerini, A; Christopoulou, A; Cantale, O; De Toma, A; Pizzutilo, P; Jimenez, B; Collazo-Lorduy, A; Calles, A; Baxevanos, P; Linardou, H; Kosmidis, P; Giannarelli, D; Mountzios, G; Addeo, A.

Efficacy of Pembrolizumab Monotherapy in Patients With or Without Brain Metastases From Advanced Non-Small Cell Lung Cancer With a PD-L1 Expression >= 50%

JOURNAL OF IMMUNOTHERAPY. 2020; 43(9): 299-306 Nº de citas: 25 [doi:10.1097/CJI.0000000000000340]

Cabezon-Gutierrez, L; Custodio-Cabello, S; Palka-Kotlowska, M; Khosravi-Shahi, P.

High-Dose 8% Capsaicin Patch in Treatment of Chemotherapy-Induced Peripheral Neuropathy. A Systematic Review

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2020; 60(5): 1047 Nº de citas: 13 [doi:10.1016/j.jpainsymman.2020.06.026]

Keilholz, U; Ascierto, PA; Dummer, R; Robert, C; Lorigan, P; van Akkooi, A; Arance, A; Blank, CU; Sileni, VC; Donia, M; Faries, MB; Gaudy-Marqueste, C; Gogas, H; Grob, JJ; Guckenberger, M; Haanen, J; Hayes, AJ; Hoeller, C; Lebbe, C; Lugowska, I; Mandala, M; Marquez-Rodas, I; Nathan, P; Neyns, B; Bagge, RO; Puig, S; Rutkowski, P; Schilling, B; Sondak, VK; Tawbi, H; Testori, A; Michielin, O.

ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee

ANNALS OF ONCOLOGY. 2020; 31(11): 1435-1448 Nº de citas: 163 [doi:10.1016/j.annonc.2020.07.004]

Michielin, O; van Akkooi, A; Lorigan, P; Ascierto, PA; Dummer, R; Robert, C; Arance, A; Blank, CU; Sileni, VC; Donia, M; Faries, MB; Gaudy-Marqueste, C; Gogas, H; Grob, JJ; Guckenberger, M; Haanen, J; Hayes, AJ; Hoeller, C; Lebbe, C; Lugowska, I; Mandala, M; Marquez-Rodas, I; Nathan, P; Neyns, B; Bagge, RO; Puig, S; Rutkowski, P; Schilling, B; Sondak, VK; Tawbi, H; Testori, A; Keilholz, U.

ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee

ANNALS OF ONCOLOGY. 2020; 31(11): 1449-1461 Nº de citas: 100 [doi:10.1016/j.annonc.2020.07.005]

Marquez-Rodas, I; Longo, F; Rodriguez-Ruiz, ME; Calles, A; Ponce, S; Jove, M; Rubio-Viqueira, B; Perez-Gracia, JL; Gomez-Rueda, A; Lopez-Tarruella, S; Ponz-Sarvise, M; Alvarez, R; Soria-Rivas, A; de Miguel, E; Ramos-Medina, R; Castanon, E; Gajate, P; Sempere-Ortega, C; Jimenez-Aguilar, E; Aznar, MA; Calvo, A; Lopez-Casas, PP; Martin-Algarra, S; Martin, M; Tersago, D; Quintero, M; Melero, I.

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors

Science Translational Medicine. 2020; 12(565): Nº de citas: 72 [doi:10.1126/scitranslmed.abb0391]

Ciruelos, E; Jerusalem, G; Martin, M; Tjan-Heijnen, VCG; Neven, P; Gavila, J; Montemurro, F; Generali, D; Lang, I; Mart?nez-Serrano, MJ; Perello, MF; Conte, P.

Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population

Clinical & Translational Oncology. 2020; 22(10): 1857-1866 Nº de citas: 3 [doi:10.1007/s12094-020-02327-5]

Pollan, M; Casla-Barrio, S; Alfaro, J; Esteban, C; Segui-Palmer, MA; Lucia, A; Martin, M.

Exercise and cancer: a position statement from the Spanish Society of Medical Oncology

Clinical & Translational Oncology. 2020; 22(10): 1710-1729 Nº de citas: 55 [doi:10.1007/s12094-020-02312-y]

Lope, V; Guerrero-Zotano, A; Casas, A; Baena-Canada, JM; Bermejo, B; Perez-Gomez, B; Criado-Navarro, I; Antolin, S; Sanchez-Rovira, P; Ramos-Vazquez, M; Anton, A; Castello, A; Garcia-Saenz, JA; Munoz, M; de Juan, A; Andres, R; Llombart-Cussac, A; Hernando, B; Franquesa, RM; Caballero, R; Priego-Capote, F; Martin, M; Pollan, M.

Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype

Nutrients. 2020; 12(10): Nº de citas: 10 [doi:10.3390/nu12103132]

Calles, A; Aparicio, MI; Alva, M; Bringas, M; Gutierrez, N; Soto, J; Arregui, M; Tirado, VC; Alvarez, EL; del Monte-Millan, M; Massarrah, T; Galera, M; Alvarez, R; Martin, M.

Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid

Frontiers in Oncology. 2020; 10: Nº de citas: 31 [doi:10.3389/fonc.2020.01777]

Escudero-Vilaplana, V; Calles, A; Collado-Borrell, R; Marzal-Alfaro, MB; Polanco, C; Garrido, C; Suarez, J; Ortiz, A; Appierto, M; Comellas, M; Lizan, L.

Standardizing Health Outcomes for Lung Cancer. Adaptation of the International Consortium for Health Outcomes Measurement Set to the Spanish Setting

Frontiers in Oncology. 2020; 10: Nº de citas: 9 [doi:10.3389/fonc.2020.01645]

Goetz, MP; Martin, M; Tokunaga, E; Park, IH; Huober, J; Toi, M; Stoffregen, C; Shekarriz, S; Andre, V; Gainford, MC; Price, GL; Johnston, S.

Health-RelatedQuality of Life inMONARCH3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy inHR+,HER2-Advanced Breast Cancer

ONCOLOGIST. 2020; 25(9): 1346-1354 Nº de citas: 52 [doi:10.1634/theoncologist.2020-0084]

Van Cutsem, E; Danielewicz, I; Saunders, MP; Pfeiffer, P; Argiles, G; Borg, C; Glynne-Jones, R; Punt, CJA; Van de Wouw, AJ; Fedyanin, M; Stroyakovskiy, D; Kroening, H; Garcia-Alfonso, P; Wasan, H; Falcone, A; Kanehisa, A; Egorov, A; Aubel, P; Amellal, N; Moiseenko, V.

Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study

ANNALS OF ONCOLOGY. 2020; 31(9): 1160-1168 Nº de citas: 51 [doi:10.1016/j.annonc.2020.05.024]

Friedlaender, A; Metro, G; Signorelli, D; Gili, A; Economopoulou, P; Roila, F; Banna, G; De Toma, A; Camerini, A; Christopoulou, A; Lo Russo, G; Banini, M; Galetta, D; Jimenez, B; Collazo-Lorduy, A; Calles, A; Baxevanos, P; Linardou, H; Kosmidis, P; Mountzios, G; Garassino, MC; Addeo, A.

Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score >= 50% treated with front-line pembrolizumab

ACTA ONCOLOGICA. 2020; 59(9): 1058-1063 Nº de citas: 36 [doi:10.1080/0284186X.2020.1781249]

Aviles-Izquierdo, JA; Nieto-Benito, LM; Lazaro-Ochaita, P; Escat-Cortes, JL; Marquez-Rodas, I; Mercader-Cidoncha, E.

Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution

Clinical & Translational Oncology. 2020; 22(9): 1611-1618 Nº de citas: 1 [doi:10.1007/s12094-020-02306-w]

Moran, T; Taus, A; Arriola, E; Aguado, C; Domine, M; Rueda, AG; Calles, A; Cedres, S; Vinolas, N; Isla, D; Palmero, R; Sereno, M; Diaz, V; Juan, O; Marse, R; Martorell, PM; Torres, JMS; Uncommon EGFR Mutations Spain.

Clinical Activity of Afatinib in Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study

Clinical Lung Cancer. 2020; 21(5): 428 Nº de citas: 22 [doi:10.1016/j.cllc.2020.04.011]

Martin, M; Guerrero-Zotano, A; Montero, A; Jara, C; Filipovich, E; Rojo, F; Moreno, F; Garcia-Saenz, JA; Ales, JE; Chacon, JI; Cruz, J; Gimenez, J; Cruz-Merino, L; Algara, M; Santisteban, M; Tarruella, SL.

GEICAMGuidelines for the Management of Patients with Breast Cancer During theCOVID-19 Pandemic in Spain

ONCOLOGIST. 2020; 25(9): 1339-1345 Nº de citas: 13 [doi:10.1634/theoncologist.2020-0363]

Sastre, J; de la Orden, V; Martinez, A; Bando, I; Balbin, M; Bellosillo, B; Palanca, S; Gomez, MIP; Mediero, B; Llovet, P; Moral, VM; Vieitez, JM; Garcia-Alfonso, P; Calle, SG; Ortiz-Morales, MJ; Salud, A; Quintero, G; Lopez, C; Diaz-Rubio, E; Aranda, E.

Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naive Metastatic Colorectal Cancer Patients Prospectively Collected

Clinical Colorectal Cancer. 2020; 19(3): 110-116 Nº de citas: 30 [doi:10.1016/j.clcc.2020.02.014]